2020
DOI: 10.1016/s1470-2045(19)30799-5
|View full text |Cite
|
Sign up to set email alerts
|

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
45
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 51 publications
(46 citation statements)
references
References 35 publications
0
45
0
Order By: Relevance
“…PD-1 blockade has been a promising therapeutic option for NKTCL [2,3], and this was corroborated by the overall response rate (47.4%, 9/19) observed in our initial retrospective pembrolizumab-treated cohort. NKTCL has been associated with ubiquitous EBV infection and, HLA-DPB1, HLA-DRB1 and IL18RAP polymorphisms, suggesting the involvement of immune evasion in its tumorigenesis [12,13]. EBV is mostly presented as a clonal episomal form with type II latency (EBNA1+, EBNA2-, and LMP1+) in NKTCL [5].…”
Section: To the Editormentioning
confidence: 99%
“…PD-1 blockade has been a promising therapeutic option for NKTCL [2,3], and this was corroborated by the overall response rate (47.4%, 9/19) observed in our initial retrospective pembrolizumab-treated cohort. NKTCL has been associated with ubiquitous EBV infection and, HLA-DPB1, HLA-DRB1 and IL18RAP polymorphisms, suggesting the involvement of immune evasion in its tumorigenesis [12,13]. EBV is mostly presented as a clonal episomal form with type II latency (EBNA1+, EBNA2-, and LMP1+) in NKTCL [5].…”
Section: To the Editormentioning
confidence: 99%
“…IL18RAP also modulates the TME and impacts cancer progression through proinflammatory functions. ILI8RAP is an accessory subunit of the heterodimeric interleukin 18 (IL18) receptor (35). CD40 is a member of the TNF receptor superfamily (36).…”
Section: Discussionmentioning
confidence: 99%
“…Recent research reported that HSPA4 is a tumor membrane antigen that can promote tumor metastasis by activating the NF-κB pathway in tumor cells once ligated with the pathogenic anti-HSPA4 IgG (Gu et al, 2019). Lin, et al indicated that the knockdown of IL18RAP inhibited cell proliferation by causing cell cycle arrest in extranodal natural killer T-cell lymphoma cells, which might be a potential therapeutic target (Lin et al, 2020). NFYC was previously identified as an important regulator in tumorigenesis of choroid plexus carcinoma (Tong et al, 2015).…”
Section: Discussionmentioning
confidence: 99%